Laurus Labs Ltd gets one observation from USFDA for Pre-Approval Inspection

US Food and Drug Administration (USFDA) today completed a PreApproval Inspection (PAI) at our manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 24th October 2022 to 28th October 2022.

The company has been issued a Form 483 with one observation. The observation is procedural in nature. The Company will address the observation within stipulated timelines.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 444.65 as compared to the previous close of Rs. 458.70. The total number of shares traded during the day was 126018 in over 3705 trades.

The stock hit an intraday high of Rs. 459.70 and intraday low of 442.95. The net turnover during the day was Rs. 56493738.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 PreApprovalInspection Form483 OneObservation